DELPHARM
Timeline
10 events since 2021Filings
Financial
Establishments
202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 21 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0763567469
Annual accounts 2024 filed PDFfull format · 14 days late
2024
Weakest financial year net €33,563 ▼78.1% The net result drops to €33,563, the lowest from 2022 to 2025. It recovers the following year.
Annual accounts 2023 filed PDFfull format · 54 days before the deadline
2023
Highest result from 2022 to 2025 net €153,031 ▲38.2% The net result of €153,031 is the highest of those years.
Equity above €200,000 equity €282,970 ▲118% With a profit in every financial year since 2022, equity grows to €282,970.
Annual accounts 2022 filed PDFfull format · 68 days before the deadline
2021
First establishment Rue de la Cloche 1, Amay
IncorporationFounding capital of €20,000, 100 shares · Founder: DUMONT Delphine Marie · Appointment: DUMONT Delphine Marie (director) · published on 16-02-20214 points ▸
- Founder, DUMONT Delphine Marie
- Founding capital, €20,000, 100 shares
- Registered office clause, rue de la Cloche 1, 4540 Amay
- Director appointment, DUMONT Delphine Marie (director (not named in the articles))
- The deed holds 10 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
DELPHARM was incorporated on 12 February 2021 as a private limited company by one natural person, with a starting capital of €20,000.12 DUMONT Delphine Marie is director of the company, appointed by deed of 16-02-2021.2 Total assets went from €1.2m in 2022 to €1.3m in 2025.3